Dinoprost
Thông số
551-11-1Số CAS
684-259-0Số EC
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acidTên IUPAC
C20H34O5Công thức hóa học
354.5 g/molKhối lượng phân tử
dinoprost; prostaglandin F2alpha; Prostaglandin F2a; PGF2alpha; amoglandin; Enzaprost; panacelan; Protamodin; l-PGF2-alpha; PGF2a; Prostaglandin F2-alpha; Dinoprosta; Dinoprostum; Prosmon; l-Prostaglandin F2-alpha; Prostarmon F; Prostin F2alpha; Prostin F2-alpha; PGF-2alpha; PGF2-alpha; cyclosin; Prostaglandin F2 alpha; 9alpha,11alpha-PGF2; U-14583; PGF2 alpha; CCRIS 4253; DTXSID9022946; HSDB 3315; (+)-Prostaglandin F2a; PGF2; Dinoprostum [INN-Latin]; U 14583; Dinoprosta [INN-Spanish]; UNII-B7IN85G1HY; (+)-Prostaglandin F2alpha; B7IN85G1HY; Prostin F 2 alpha; BRN 2225571; U-14,583; 9a,11a-PGF2; (5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid; DTXCID602946; CHEBI:15553; 7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid; Dinaprost; 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, l-; 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(S*,E),3alpha,5alpha))-; Dinoprostum (INN-Latin); Dinoprosta (INN-Spanish); DINOPROST (MART.); DINOPROST [MART.]; (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid; (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate; 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid; (5Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid; alpha, PGF2; Prostaglandin-F2alpha; 7-(3, 5-dihydroxy-2-(3-hydroxyl-1-octenyl) cyclopentyl)-5-heptenoic acid; F2alpha, Prostaglandin; 9alpha,11beta PGF2; RefChem:56456; F2 alpha, Prostaglandin; G02AD01; 551-11-1; Enzaprost F; Prostaglandin F2.alpha.; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid; PGF2.alpha.; (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid; MFCD00135231; 23518-25-4; CHEMBL815; NCGC00160385-01; (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid; 9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid; Prostaglandin F(sub 2a); Dinoprost [USAN:INN:BAN:JAN]; (+-)-PGF2alpha; SR-01000721847; (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid; (+-)-PGF2-alpha; dl-Prostaglandin F2-alpha; PGF2-alpha racemic mixt.; Prostaglandin F2alpha, dl-; Dinoprost?; (Z)-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(E,3S)-3-oxidanyloct-1-enyl]cyclopentyl]hept-5-enoic acid; 9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid; Prosmon (TN); Dinoprost (Standard); Prostaglandin F2-alpha, racemic mixt.; BRN 4153898; Cloprostenol Impurity 4; DINOPROST [INN]; DINOPROST [JAN]; DINOPROST [HSDB]; DINOPROST [USAN]; (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-3,13-dien-1-oic acid; DINOPROST [WHO-DD]; Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-; SCHEMBL24292; BSPBio_001494; BML1-F08; GTPL1884; orb1308381; orb3141499; Dinoprost (JP18/USAN/INN); 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid; EX-A4115A; HMS1361K16; HMS1791K16; HMS1989K16; HMS2089F11; HMS3402K16; HMS3648N11; (E,Z)-(1R,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid; MSK11386; Tox21_111777; BDBM50035622; EBC-26711; HY-12956R; LMFA03010002; PDSP2_000079; AKOS030526160; PROSTAGLANDIN F2.ALPHA. [MI]; CCG-208257; CS-4232; DB12789; FP27242; 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (+-)-; 5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-1-OCTENYL)CYCLOPENTYL)-, dl-; IDI1_033964; Dinoprost; Prostaglandin F2a; PGF2alpha; NCGC00160385-02; NCGC00160385-04; NCGC00160385-05; NCGC00160385-06; AS-56892; CAS-551-11-1; HY-12956; NS00124545; P1885; A12628; C00639; D00081; T15133; EN300-21689745; F866227; Q421375; SR-01000946457; SR-01000721847-2; SR-01000721847-4; SR-01000946457-1; BRD-K81672972-001-03-1; (5Z,9a,11a,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid; (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate; (5z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprosta-5,13-dienoic acid; 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic a cid; Prosta-10,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S); Prostaglandin F2alpha; Prostaglandin F2a; Enzaprost; Dinoprost; Amoglandin; Cyclosin; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3S)-3-hydroxy-1-octenyl}-cyclopentyl]-5-heptenoic acid; 13535-33-6; Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-(+-)-Tên gọi khác
